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Several mutations were introduced into the putative serine protease domain of the tick-borne encephalitis virus NS3 protem and mto a possible 
internal cleavage site wtthm the protein. The influence of these mutations on proteolytic activity of NS3 protein and NS3’ protem formation was 
tested m vitro. It was found that NS3’ formation was not dependent on the activity of the NS3 N-terminal serme protease. Mutations affecting 
the Ser-138 residue of the NS3 protein prohibited cleavage between NS2B and NS3 protems when the NS2B-NS3 part of the viral genome was 
expressed m vitro. suggesting the key role of Ser-138 in viral serme protease functioning. 
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1. INTRODUCTION 
Tick-borne encephalitis virus (TBEV) belongs to the 
Flaviviridae, a family of positive-stranded RNA viruses 
the genomes of which contain a single long open reading 
frame [l]. Computer analysis of flavivirus polyproteins 
has revealed homology between trypsin-like serine pro- 
teases and the N-terminal 180 a.a. of the flaviviral non- 
structural protein NS3 [2,3]. Previously we found in 
TBEV-infected mammalian cells in addition to the full- 
length NS3 protein (69 kDa) a short form of the TBEV 
NS3 protein (49 kDa; called NS3’) and proposed that 
NS3’ was formed due to autocatalytic internal cleavage 
of the NS3 protein by its own N-terminal serine pro- 
tease at a potential internal cleavage site [4]. In this 
work, to prove the hypothesis that the N-terminus of 
the TBEV NS3 protein contains a serine protease and 
to check our proposal on NS3’ formation, we intro- 
duced several mutations into the putative serine pro- 
tease domain of NS3 and the potential internal cleavage 
site of the protein and tested their influence on the 
proteolytic activity of NS3 and NS3’ protein formation 
in vitro. 
2. MATERIALS AND METHODS 
2.1. Constructron of mitral reconlhmant plasnzldJ 
Standard methods for m vttro DNA manipulations and plasmid 
DNA cloning were essentially as described [5] 
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To introduce a termination codon mto the 3’ end of the TBEV NS3 
gene coding region, the polylinker BunrHI-HltrdIII part of the plasmid 
pGEM2-NS3 [4] was replaced by a synthetic DNA-fragment com- 
posed of ohgonucleotides. 5’-GATCCTGTAATAAAAA and S- 
AGCTTTTTTATTACAG The resultant plasmid pS-NS3 was se- 
lected. In the same manner the termination codon was mtroduced into 
pGEM2-NS3* [4]. and the plasmtd pS-NS3* &as selected. 
Plasmid pG123, containing the NSl-NS2A-NS2B-NS3 portion of 
the TBEV genome (Dobrikova, unpubhshed), was used to obtain the 
TBEV NS2B-NS3 gene block. The hioI’(4,185)-PstI(5.345) fragment 
was cut from the pG123 plasmid (the NwI site precedes the beginning 
of NSZB gene: sign ‘#’ means that a marked 5’-overhanging end was 
made blunt with the Klenow fragment: numbering of the TBEV nucle- 
otides and ammo acid residues is according to [6]). This fragment was 
hgated with large SufI”~PsrI fragment of the pS-NS3* plasmid. and 
the resulting pS-2B3 plasmid was selected which carries TBEV NS?B- 
NS3 gene block suitable for m vitro expression. 
2.2 Site-dwectetl tmrtagcnesis on the gupped uplex plustmd DNA 
The procedure used was a modified method designed for ohgonucle- 
otide-directed mutagenesis on the M 13 phage DNA [7]. The modifica- 
ttons were: (i) pTZ18R plasmid vector was used (instead of Ml3 
phage) to produce single-stranded (ss) target DNA (TBEV NS3 gene 
was cut from the pS-NS3 plasmid vvtth EcoRI and HrndIII and re- 
cloned mto pTZ18R. yieldmg m pTZ18RNS3 plasmid), (ii) ss-target 
DNA was prepared using E. toll RZl032 (ung-. dutt) cells [8] (helper 
phage was M13K07) Such ss-DNA is partially ‘uracylated’ and IS 
quickly destroyed m the (ung’. dut’) E colr strains. 
Selection of the required mutants (plasmids pGTA, pGIP. pGST. 
pGAP, pHCTG and pQRSW: see Table I) was made by restriction 
analysts of plasmid DNAs and sequencmg of respective plasmid re- 
gions according to [9]. 
Choice of the primers for mutagenesis (Table I) was made using the 
program ‘DIROM’ designed to facilitate the ohgonucleotide-directed 
mutagenesis experiments [lo] Primers were selected according to the 
followmg requirements: (I) they must Introduce one of rare restriction 
sites into the DNA at the place of mutation, to facilitate mutant clones 
selection: (ii) mutation should lead to amino acid substitution(s); (III) 
primers should be specific to the target DNA, providmg high effi- 
ciency of annealing and low level of alternative attachment. 
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3.3. Introductrorl of mututions D-MO the NSZB-NSj gene block 
(i) Into NS3 protease catalytlcal center of NS2B-NS3 gene block: 
the SucI(4,910)-SuLI(5.117) fragment of the pS-2B3 plasmid insert was 
replaced by the same fragment but dertved from the pGTA. pGIP. 
pGST, or pGAP. The plasmids pS-2B3/GTA. pS-2B3/GIP, pS-2B3/ 
GST and pS-2B3/GAP were selected. 
(11) Into proposed mternal NS3 cleavage site of the block. the 
Bgfl(5.956)-Bg/II(6.330) part of pS-2B3 Insert was replaced by the 
ones cut from pHCTG or pQRSW. The plasmids pS-2B3/HCTG and 
pS-3B3/QRSW were selected 
2.4 hi wtro tramcription und translat~orl 
These procedures as well as immunoprecipttatton of ‘“S-labeled 
translation products and their analysis m 7.5525% SDS-PAGE were 
essentially as described previously [4]. 
3. RESULTS AND DISCUSSION 
3.1. NS3 N-ternkal serine protease activity is not re- 
quired ji)r TBEV NS3’ protein formation 
To check our recent proposal [4] that TBEV NS3’ 
may be generated due to internal autocatalytic cleavage 
of the full-length NS3 by its putative N-terminal serine 
protease domain, site-directed mutagenesis of the 
TBEV NS3 gene was carried out. Mutagenic primers 
and mutations introduced into the predicted main 
pocket (136-GTSGSP [3,3]) of the NS3 serine protease 
catalytic center and the potential internal 459-RRG- 
cleavage site of the protein [4] are listed in Table I. 
The RNAs transcribed from the pGTA, pGIP, 
pGST, pGAP, pHCTG, pQRSW and pTZ18R-NS3 
plasmids (which are based on pTZ18R) by T7 RNA 
polymerase were not active in stimulating translation in 
rabbit reticulocyte lysates. Therefore the mutant vari- 
ants of the TBEV NS3 gene were excised from pGTA, 
pGIP, pGST, pGAP. pHCTG and pQRSW plasmids 
with EcoRI and Hind111 and recloned in a pGEM2 
vector. The resulting plasmids pS-GTA. pS-GIP, pS- 
GST, pS-GAP, pS-HCTG and pS-QRSW were digested 
with Hind111 and transcribed with SP6 RNA-polym- 
erase. These RNAs were successfully translated in rab- 
bit reticulocyte lysate (Fig. 1). Although the reason for 
such an observation is unknown, it is likely to be ac- 
counted for by the diversity of the S-ends of the TBEV 
NS3-mRNAs, generated by means of pTZ18R and 
pGEM2 vectors, which may influence secondary struc- 
ture of the mRNAs and initiation of their translation on 
the eucaryotic ribosomes. For the pTZlSR-NS3 (inac- 
tive mRNA is produced with T7 RNA polymerase) and 
pS-NS3 (active mRNA under SP6 RNA-polymerase 
transcription). 5’-ends of the mRNAs are: S-cap- 
GGGAATTCCCCGATAA.. . and S-cap-GAATAC- 
ACGGAATTCCCCGATAA..., respectively (EcoRI- 
sites are in bold). 
Fig. 1 shows that neither mutations in the putative 
NS3 N-terminal protease catalytic domain nor in the 
internal RRG-site influence the formation of NS3’ pro- 
tein (49 kDa). Hence the TBEV NS3’ protein formation 
is not due to activity of the viral serine protease. 
There may be two other possible mechanisms for 
TBEV NS3’ formation. (i) NS3’ may be formed in a 
similar manner to that shown for dengue virus polypro- 
tein cleavage at the NSl/NS2A junction [I 1,121. This 
proteolysis occurs autocatalytically, however no pro- 
tease motifs have been found within the flavivirus NSl 
and NS2A amino acid sequences. (ii) NS3’ may also be 
formed due to co- or post-translational proteolysis of 
the full-length NS3 by a cellular protease (E. Koonin, 
personal communication). 
Table I 
Oligonucleottdes (mutagemc primers) used for site-directed mutagenesis of the TBEV NS3 gene and mutations m the NS3 protein Induced by them. 
Designa- 
tion 
Ohgonucleotide structure Mutation 
induced 
Restriction 
site 
induced 
Resulting 
plasmtd 
designation 
PI52 
* 
GGGACAGCTGGCAGTCC (4.999-5.015) 
,l,627(138) 
GTSGSP 4 GTAGSP PLUII 
P153 
P154 
P155 
*** 
AGGGGATCCCTGGCAGTC (4.997-5.014) 
GGCAAAGGGG;C&TGGCAG (4.99225.012) 
*** 
GACATCTGGAGCTCCCATCC (5,OOlL5,020) 
GTSGSP -+ GIPGSP 
GTSGSP --f GSTGSP 
GTSGSP + GTSGAP 
BuntHI 
SUII 
Sac1 
** * 
P156 GCGGCCCACTGCAGTGGGAGAG (5.962-5.983) 
! 943459) 
QRRG 3 HCTG PstI 
* ** 
P157 GGCCCAACGCAGCTGGAGAGTC (539645,985) QRRG -+ QRSW PruII 
Changed 
pS-GTA 
pS-GIP 
pS-GST 
pS-GAP 
pS-HCTG 
pS-QRSW 
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Fig. 1. Expression of the TBEV NS3 gene and its mutant forms m 
vitro The autoradiogram of an SDS-PAGE dtsplays immunoprectpi- 
tated protein patterns from in vitro translation mtxtures programmed 
wtth mRNAs produced from the plasmid templates indicated above 
each hne. In the ‘-RNA’ lane no mRNA was added The asterisk 
indicates a background band localizatton vistble on the ‘-RNA‘ line 
too upon much longer exposure. Positions of molecular weight mark- 
Fig. 2. Expression of the Intact and mutant TBEV NS2B/NS3 gene 
block in vitro. Plasmtd templates for respective mRNAs that were 
translated are mdtcated above each hne. The P2 mRNA encoding the 
C-terminally truncated form of the TBEV NS3 protein (65 kDa) was 
prepared as described previously [4]. The ‘P2+pS-2B3/GIP’ line shows 
the result of stmultaneous translation of P2 mRNA and the one pro- 
duced from the pS-2B3/GIP plasmid In the ‘-RNA’ lane no mRNA 
was added. The asterisk Indicates a background band localizatton 
vistble on the ‘-RNA’ line too upon much longer exposure. ‘?’ denotes 
additional bands observed the nature of which is not clear. Posttions 
ers are indicated. of molecular weight markers are indicated. 
3.2. Injluence of the mutations in NS3 gene on the TBEV 
NS2B-NS3 block processing 
As was shown for dengue and yellow fever viruses, 
the N-terminal domain of NS3 is necessary for cleavage 
at the NS2B/NS3 junction as well as at the NS2A/NS2B 
and NS3/NS4A junctions [ 133151. NS2B is also required 
for these cleavages [14]. With these viruses, the NS3 
serine protease acts only in cis when performing the 
hydrolysis between NS2B/NS3. Thus it was of interest 
to investigate how the TBEV NS2B-NS3 block would 
be processed in vitro and what effect on this process 
would be caused by mutations in the NS3 gene. 
kDa 
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The plasmids pS-2B3/GTA, pS-2B3/GIP. pS-2B3/ 
GST, pS-2B3/GAP, pS-2B3/HCTG and pS-2B3/QRSW 
(see section 2) as well as the initial pS-2B3 plasmid were 
linearized with Hind111 and used as templates for in 
vitro transcription with SP6 RNA-polymerase. 
Translation of the original NS2B/NS3 TBEV gene 
block (plasmid pS-2B3) led to the appearance of la- 
belled products with molecular weights of 69,49 and 14 
kDa (presumably NS3, NS3’ and NS2B). Some amount 
of unprocessed precursor (83 kDa) was also visible (Fig. 
2). The same pattern was observed with pS-2B3/GAP, 
pS-2B3/HCTG and pS-2B3/QRSW. Only unprocessed 
83 kDa product was produced when mRNAs tran- 
scribed from the pS-2B3/GTA, pS-2B3/GIP and pS- 
2B3/GST were translated. Summing up, the following 
conclusions may be made: 
(i) The NS2B-NS3 region of the TBEV polyprotein 
is processed in vitro and individual NS’B, NS3 and 
NS3’ are formed. The mutations GTS + GTA, 
GTS + GIP and GTS -+ GST affecting the Ser-I 38 
residue of NS3 fully inhibit the NS’B-NS3 block proc- 
essing. Therefore the N-terminal part of TBEV NS3 
represents a domain of the virus serine protease which 
is responsible for the cleavage at the NS2B/NS3 junc- 
tion and Ser-138 plays a key role in the enzyme func- 
tioning. 
(ii) Rearrangement of the NS3 Thr-137 and Ser-138 
residues inhibits the virus protease activity suggesting 
that a correct order of amino acids in the catalytic cen- 
ter is essential for the enzyme to function. 
(iii) The point mutation Ser-140 + Ala does not in- 
fluence activity of the TBEV NS3 protease. Conse- 
quently Ser-140 is not required for protease activity. 
This residue cannot perform a compensatory function 
in the case of mutations affecting Ser-I 38 because a 
relatively gentle substitution Ser- 138 + Ala [ 161 or rear- 
rangement of Thr-137 and Ser-138 block the protease 
activity completely. 
(iv) As was demonstrated when NS3 and NS3 mu- 
tants were expressed individually, the formation of NS3’ 
cannot be attributed to the activity of the NS3 serine 
protease. However, the mutations in the enzyme cata- 
lytic center, preventing the cleavage between NS2B and 
NS3 (when the NS2B-NS3 gene block is expressed), 
inhibit NS3’ formation. Therefore in the course of the 
NS2B-NS3 part of the TBEV polyprotein processing, 
NS2B must be removed to yield a free NS3 protein 
N-terminus after which formation of NS3’ can occur. 
Such an order of processing events observed in vitro 
may reflect the real course of events in TBEV-infected 
cells. 
(v) The N-terminal serine protease of TBEV NS3 is 
most probably cis-acting when it cleaves the NS2B/NS3 
junction because simultaneous translation of the mu- 
tant NS2B-NS3-mRNA (pS-2B3/GIP) and mRNA P2 
produced as described previously [4] (the translation 
product may serve as a trmzs-acting protease) did not 
lead to the appearance of individual NS3 and NS2B 
(Fig. 2). The P2 mRNA used encodes a product of 
approximately 6.5 kDa which is a deletion mutant of 
NS3 protein truncated from the C-terminus. 
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